Home
>
National Drug Code (NDC)
>
Carisoprodol
Carisoprodol - 0591-5513-05 - (Carisoprodol)
Drug Information of Carisoprodol
| Product NDC: | 0591-5513 |
| Proprietary Name: | Carisoprodol |
| Non Proprietary Name: | Carisoprodol |
| Active Ingredient(s): | 350 mg/1 & nbsp; Carisoprodol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carisoprodol
| Product NDC: | 0591-5513 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA087499 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19871101 |
Package Information of Carisoprodol
| Package NDC: | 0591-5513-05 |
| Package Description: | 500 TABLET in 1 BOTTLE (0591-5513-05) |
NDC Information of Carisoprodol
| NDC Code | 0591-5513-05 |
| Proprietary Name | Carisoprodol |
| Package Description | 500 TABLET in 1 BOTTLE (0591-5513-05) |
| Product NDC | 0591-5513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carisoprodol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19871101 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | CARISOPRODOL |
| Strength Number | 350 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
